Aclaris Therapeutics, Inc. Capital Expenditures
Aclaris Therapeutics, Inc. (ACRS) reported Capital Expenditures of $71.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- Aclaris Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $58.00K, a 176.19% increase year-over-year.
- Aclaris Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $13.00K, a 69.77% decline year-over-year.
- Aclaris Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $24.00K.
- Aclaris Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $23.00K.
- Aclaris Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $111.00K, a 8.26% decline from fiscal 2024.
- Aclaris Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $121.00K, a 90.76% decline from fiscal 2023.
- Aclaris Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $1.31M, a 116.36% increase from fiscal 2022.
- Aclaris Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $605.00K, a 96.43% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $71.00K 10-Q · filed 2026-08-06 | $95.00K derived: sum of 3 quarters · filed 2026-08-06 | $118.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $13.00K 10-Q · filed 2026-05-07 | $37.00K derived: sum of 2 quarters · filed 2026-05-07 | $60.00K derived: sum of 3 quarters · filed 2026-05-07 | $81.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $47.00K derived: sum of 2 quarters · filed 2026-02-26 | $68.00K derived: sum of 3 quarters · filed 2026-08-06 | $111.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $44.00K derived: sum of 2 quarters · filed 2026-08-06 | $87.00K 10-Q · filed 2025-11-06 | $87.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $64.00K 10-Q · filed 2026-08-06 | $64.00K derived: sum of 3 quarters · filed 2026-08-06 | $64.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $43.00K 10-Q · filed 2026-05-07 | $43.00K derived: sum of 2 quarters · filed 2026-05-07 | $43.00K derived: sum of 3 quarters · filed 2026-05-07 | $29.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | -$14.00K derived: sum of 3 quarters · filed 2026-02-26 | $121.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$14.00K derived: sum of 2 quarters · filed 2025-11-06 | $121.00K 10-Q · filed 2025-11-06 | $562.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $121.00K 10-Q · filed 2025-08-07 | $562.00K derived: sum of 3 quarters · filed 2025-08-07 | $646.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $135.00K 10-Q · filed 2025-05-08 | $576.00K derived: sum of 2 quarters · filed 2025-05-08 | $660.00K derived: sum of 3 quarters · filed 2025-05-08 | $891.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $441.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $525.00K derived: sum of 2 quarters · filed 2025-02-27 | $756.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.31M 10-K · filed 2025-02-27 |
| 2023-09-30 | $84.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $315.00K derived: sum of 2 quarters · filed 2024-11-06 | $868.00K 10-Q · filed 2024-11-06 | $973.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $231.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $784.00K 10-Q · filed 2024-08-07 | $889.00K derived: sum of 3 quarters · filed 2024-08-07 | $1.04M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $553.00K 10-Q · filed 2024-05-07 | $658.00K derived: sum of 2 quarters · filed 2024-05-07 | $808.00K derived: sum of 3 quarters · filed 2024-05-07 | $994.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $255.00K derived: sum of 2 quarters · filed 2024-02-27 | $441.00K derived: sum of 3 quarters · filed 2024-02-27 | $605.00K 10-K · filed 2024-02-27 |
| 2022-09-30 | $150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $336.00K derived: sum of 2 quarters · filed 2023-11-06 | $500.00K 10-Q · filed 2023-11-06 | $700.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $186.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $350.00K 10-Q · filed 2023-08-07 | $550.00K derived: sum of 3 quarters · filed 2024-02-27 | $606.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $164.00K 10-Q · filed 2023-05-08 | $364.00K derived: sum of 2 quarters · filed 2024-02-27 | $420.00K derived: sum of 3 quarters · filed 2024-02-27 | |
| 2021-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $256.00K derived: sum of 2 quarters · filed 2024-02-27 | $308.00K 10-K · filed 2024-02-27 | |
| 2021-09-30 | $56.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $108.00K 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $52.00K 10-Q · filed 2022-08-03 | |||
| 2020-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $312.00K derived: sum of 2 quarters · filed 2023-02-23 | $329.00K derived: sum of 3 quarters · filed 2023-02-23 | $453.00K 10-K · filed 2023-02-23 |
| 2020-09-30 | $304.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $321.00K derived: sum of 2 quarters · filed 2021-11-02 | $445.00K 10-Q · filed 2021-11-02 | $711.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $141.00K 10-Q · filed 2021-08-05 | $407.00K derived: sum of 3 quarters · filed 2022-02-24 | $1.23M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $124.00K 10-Q · filed 2021-05-07 | $390.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.21M derived: sum of 3 quarters · filed 2022-02-24 | $1.45M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $266.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.09M derived: sum of 2 quarters · filed 2022-02-24 | $1.33M derived: sum of 3 quarters · filed 2022-02-24 | $1.61M 10-K · filed 2022-02-24 |
| 2019-09-30 | $822.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $1.06M derived: sum of 2 quarters · filed 2020-11-04 | $1.35M 10-Q · filed 2020-11-04 | $1.49M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $241.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $525.00K 10-Q · filed 2020-08-07 | $671.00K derived: sum of 3 quarters · filed 2021-02-25 | $1.23M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $284.00K 10-Q · filed 2020-05-07 | $430.00K derived: sum of 2 quarters · filed 2021-02-25 | $990.00K derived: sum of 3 quarters · filed 2021-02-25 | $1.34M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $706.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.06M derived: sum of 3 quarters · filed 2021-02-25 | $1.36M 10-K · filed 2021-02-25 |
| 2018-09-30 | $560.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $912.00K derived: sum of 2 quarters · filed 2019-11-07 | $1.21M 10-Q · filed 2019-11-07 | $1.79M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $352.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $650.00K 10-Q · filed 2019-08-08 | $1.23M derived: sum of 3 quarters · filed 2020-02-25 | $1.50M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $298.00K 10-Q · filed 2019-05-08 | $875.00K derived: sum of 2 quarters · filed 2020-02-25 | $1.15M derived: sum of 3 quarters · filed 2020-02-25 | $1.34M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $577.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $847.00K derived: sum of 2 quarters · filed 2020-02-25 | $1.04M derived: sum of 3 quarters · filed 2020-02-25 | $1.24M 10-K · filed 2020-02-25 |
| 2017-09-30 | $270.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $463.00K derived: sum of 2 quarters · filed 2018-11-06 | $658.00K 10-Q · filed 2018-11-06 | $720.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | $193.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $388.00K 10-Q · filed 2018-08-03 | $450.00K derived: sum of 3 quarters · filed 2019-03-18 | $514.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | $195.00K 10-Q · filed 2018-05-08 | $257.00K derived: sum of 2 quarters · filed 2019-03-18 | $321.00K derived: sum of 3 quarters · filed 2019-03-18 | $387.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2016-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $126.00K derived: sum of 2 quarters · filed 2019-03-18 | $192.00K derived: sum of 3 quarters · filed 2019-03-18 | $232.00K 10-K · filed 2019-03-18 |
| 2016-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $130.00K derived: sum of 2 quarters · filed 2017-11-07 | $170.00K 10-Q · filed 2017-11-07 | $302.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $106.00K 10-Q · filed 2017-08-08 | $238.00K derived: sum of 3 quarters · filed 2018-03-12 | $371.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $40.00K 10-Q · filed 2017-05-09 | $172.00K derived: sum of 2 quarters · filed 2018-03-12 | $305.00K derived: sum of 3 quarters · filed 2018-03-12 | $470.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $265.00K derived: sum of 2 quarters · filed 2018-03-12 | $430.00K derived: sum of 3 quarters · filed 2018-03-12 | $507.00K 10-K · filed 2018-03-12 |
| 2015-09-30 | $133.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $298.00K derived: sum of 2 quarters · filed 2016-11-03 | $375.00K 10-Q · filed 2016-11-03 | $644.00K derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $165.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $242.00K 10-Q · filed 2016-08-11 | $511.00K derived: sum of 3 quarters · filed 2017-03-15 | |
| 2015-03-31 | $77.00K 10-Q · filed 2016-05-11 | $346.00K derived: sum of 2 quarters · filed 2017-03-15 | ||
| 2014-12-31 | $269.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $417.00K 10-K · filed 2017-03-15 | ||
| 2014-09-30 | $148.00K 10-Q · filed 2015-12-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |